MD. Zviad Eradze
Clinical Scientist

Medical Doctor in Cardiology

Personal Data:

Surname, First Name:

Zviad Eradze

Investigational Site Name and Address
(incl. Department, Country):

LTD Diacor, Georgia, Tbilisi, Lubliana 5, 0159, 5th floor  

 


Languages:

English

Native 

Read  

Written 

Spoken 

Georgian

Native 

Read  

Written  

Spoken  


   

Education at College/University/Medical School Level:

Qualification:

Year:

                       2001


Institution/Country:

Therapeutist

Tbilisi Medical University, “Skhivi” Georgia

 

Details of Authorization to practise : 

Year:

Expiry / Renewal Date (mark NA if not applicable):

Kind of Authorization (e.g. Medical License, nurse Registration No., ID No., Certification, etc.)/Institution/Country/State/Province :

 

2001

 

NA


Medical Diploma N 0003756, Tbilisi Medical University, “Skhivi” Georgia


 

2005

NA


Certificate Cardiologist 

 N 002157

Ministry of Labour, Health and Social Affairs

Examinations for Speciality:

Year:

2005

Speciality:

 

Cardiologist 

 







Details of Employment:

Post Graduate Positions:

From

To

Institution/Country:

Cardiologist 

 

Cardiologist 

 

 

Cardiologist

 

Cardiologist 

 

 

Cardiologist 

 

2015

 

2012

 

 

2011

 

2010

 

 

2005

 till now

 

 2015

 

 

2012

 

2012

 

 

2010

 

LTD Diacor, Tbilisi, Georgia

 

The Centre for Diabetes, Endocrine  and Cardio-pulmonary Diseases, Tbilisi, Georgia 

 

Cardiovascular disease centre, Tbilisi, Georgia

 

“Samgori “Clinical Centre, Tbilisi, Georgia

 

 

“Randi” Cardiologic Centre, Tbilisi, Georgia

Current Position:

(e.g. Head of Department, Hospital Assistant, Lecturer, Nurse)

From

Institution Name and Address:

Cardiologist

 

2015

LTD Diacor , Georgia. Tbilisi,  Lubliana 5, 0159, 5th floor


Experience in Clinical Trials (Phase, Therapeutic area(s) and Responsibility (ies) (e.g. Principal Inv, Sub-Inv., Nurse):

 

PI - Phase III  A Study of Rivaroxaban on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients 

 

 

SC - Phase III Diabetes Mellitus type 2 micro vascular complications study 

SI -  Phase III COPD treatment study (2014-2015 finished)

SI -  Phase III pneumonia treatment study (2014-2015 (finished)

 

 

Type of GCP training (e.g. GCP Course, Investigator meeting):

Date of  Last GCP Training:

GCP for Investigational Site Staff

2018

Publications (No. of articles published, therapeutic area):